Zomedica Corp.
ZOM was delisted on the 4th of March, 2025.
7 hedge funds and large institutions have $126K invested in Zomedica Corp. in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and 3 closing their positions.
10% less capital invested
Capital invested by funds: $141K → $126K (-$14.4K)
22% less funds holding
Funds holding: 9 → 7 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EWA
EverSource Wealth Advisors
Birmingham,
Alabama
|
+$1 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$53K |
| 2 |
HFS
Hantz Financial Services
Southfield,
Michigan
|
-$1K |
| 3 |
CSP
Cary Street Partners
Richmond,
Virginia
|
-$892 |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$272 |
| 5 |
RF
Rossby Financial
Melbourne,
Florida
|
-$8 |
ZOM Hedge Fund Activity: Q4 2025 in Review
7 of the 8,224 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q4 2025, worth a combined $126K — down 10% from $141K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ZOM and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 0 added.
The largest buyer was EverSource Wealth Advisors, opening a new position worth an estimated $1. The largest seller was Ancora Advisors, cutting an estimated $53K.
- 7 institutional investors held Zomedica Corp. (ZOM) as of Q4 2025, down from 9 in Q3 2025.
- Funds reported $126K of Zomedica Corp. stock for Q4 2025, down 10% quarter-over-quarter.
- 1 fund opened new Zomedica Corp. positions in Q4 2025 and 3 closed out, a net change of -2 holders.
- The largest Zomedica Corp. buyer in Q4 2025 was EverSource Wealth Advisors, an estimated $1 added.
- The largest Zomedica Corp. seller in Q4 2025 was Ancora Advisors, an estimated $53K sold.
Based on aggregated 13F filings for Q4 2025.